Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Cardiology/Vascular Diseases | Endocrinology | Family Medicine

High Cholesterol (Hyperlipidemia) Clinical Trials

A listing of High Cholesterol (Hyperlipidemia) medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  ... Last 

Alabama

Advanced Cardiovascular, LLC
Auburn Alabama

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome

Heart Center Research, LLC
Huntsville Alabama

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome

University of South Alabama Medical Center
Mobile Alabama

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome

IMC Diagnostic and Medical Clinic
Mobile Alabama

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome

Acurian
Athens Alabama 35611

High Cholesterol Research Study

Research Site
Birmingham Alabama 35294

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER)

Acurian
Birmingham Alabama 35294

High Cholesterol Research Study

Acurian
Huntsville Alabama 35801

High Cholesterol Research Study

Research Site
Mobile Alabama 36608

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER)

View More »

Pfizer Investigational Site
Athens Alabama 35611

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Pfizer Investigational Site
Athens Alabama 35611

A clinical trial seeking patients for a research study for the treatment of Hyperlipidemia

Pfizer Investigational Site
Athens Alabama 35611

A Phase 3 clinical study for patients with Cardiovascular Disease

Pfizer Investigational Site
Birmingham Alabama 35233

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Pfizer Investigational Site
Birmingham Alabama 35294

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Pfizer Investigational Site
Birmingham Alabama 35216

A Phase 3 clinical study for patients with Hyperlipidemia

Pfizer Investigational Site
Huntsville Alabama 35801

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Arizona

Verde Valley Medical Center
Cottonwood Arizona

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome

Mayo Clinic Arizona
Phoenix Arizona

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome

University of Arizona
Tucson Arizona

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome

Research Site
Glendale Arizona 85306

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER)

Acurian
Glendale Arizona 85308

High Cholesterol Research Study

Research Site
Phoenix Arizona 85018

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER)

Research Site
Tucson Arizona 85712

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER)

Acurian
Tucson Arizona 85712

High Cholesterol Research Study

Acurian
Tucson Arizona 85710

High Cholesterol Research Study

View More »

Pfizer Investigational Site
Glendale Arizona 85308

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Pfizer Investigational Site
Phoenix Arizona 85018

A clinical trial seeking patients for a research study for the treatment of Hyperlipidemia

Pfizer Investigational Site
Tempe Arizona 85282

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Pfizer Investigational Site
Tempe Arizona 85282

A clinical trial seeking patients for a research study for the treatment of Hyperlipidemia

Pfizer Investigational Site
Tempe Arizona 85282

A Phase 3 clinical study for patients with Cardiovascular Disease

Pfizer Investigational Site
Tempe Arizona 85282

A Phase 3 clinical study for patients with Hyperlipidemia

Pfizer Investigational Site
Tucson Arizona 85710

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Pfizer Investigational Site
Tucson Arizona 85710-2193

A clinical trial seeking patients for a research study for the treatment of Hyperlipidemia

Pfizer Investigational Site
Tucson Arizona 85710

A clinical trial seeking patients for a research study for the treatment of Hyperlipidemia

Pfizer Investigational Site
Tucson Arizona 85710

A Phase 3 clinical study for patients with Cardiovascular Disease

Pfizer Investigational Site
Tucson Arizona 85710

A Phase 3 clinical study for patients with Hyperlipidemia

Arkansas

Arkansas Cardiology, PA
Little Rock Arkansas

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome

View More »

Arkansas Children's Hospital
Little Rock Arkansas 72202

A clinical study for patients using Ampicillin

California

Central Cardiology Medical Center
Bakersfield California

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome

Beaver Medical Group
Banning California

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome

Cardiovascular Medical Group of Southern California
Beverly Hills California

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome

Med Investigations
Fair Oaks California

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome

Bala and Khaira Medical Research Center
Fresno California

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome

Saint Jude Medical Center
Fullerton California

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome

National Institute of Clinical Research
Huntington Beach California

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome

Purushotham and Akther Kotha MD, Inc.
La Mesa California

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome

Kumar Medical Corporation
Lancaster California

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome

V.A. Medical Center
Long Beach California

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome

Long Beach Memorial  Medical  Center
Long Beach California

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome

Los Alamitos Cardiovascular
Los Alamitos California

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome

First 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  ... Last